Peter Heinrich, PhD
Partner, Munich, Germany
Dr. Peter Heinrich studied biology and chemistry at Munich University where he received a PhD in biochemistry and was a post-doc scientist at Harvard University. He has over 20 years of experience in the pharma and biotech industry in R&D, drug development, licensing, new drug commercialization and business & corporate development and general management. He has been directly involved in start-up ventures, as well as publicly-held entities, improving shareholder value, and M&A agreements. He is a serial entrepreneur, serving as a Co-founder at Sinfonie Life Science Management GmbH, Co-founder and CEO of MediGene AG and co-founder of the leading immune-oncology players Immunocore and Adaptimmune in Oxford and others. He was also CEO of MagForce AG, a publicly listed MedTech company. He is Chairman of BIO Deutschland, the German Biotech Association, and Vice Chairman of EuropaBio, the European Biotech Association. He also acts as Chairman of the Biotech company Syntab Therapeutics. Since 2017 he is also a member of the Board of the Federation of German Industries (BDI), the voice of the German industry.